Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alejandra Larrieux"'
Autor:
Alejandra Larrieux, Rafael Sanjuán
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Oncolytic virotherapy has shown efficacy in various animal models and a few human cancers. However, there are still significant limitations for the implementation of these therapies. One such limitation is the emergence of cellular resistanc
Externí odkaz:
https://doaj.org/article/5a426ff5b21046029824bc5108a65544
Autor:
Alejandra Larrieux, Rafael Sanjuán
Publikováno v:
iScience, Vol 26, Iss 1, Pp 105749- (2023)
Summary: The emergence of cellular resistances to oncolytic viruses is an underexplored process that could compromise the efficacy of cancer virotherapy. Here, we isolated and characterized B16 mouse melanoma cells that evolved resistance to an oncol
Externí odkaz:
https://doaj.org/article/8765603c9a8646f187c79bdb371b8935
Autor:
Alejandra Larrieux, Rafael Sanjuán
Publikováno v:
iScience. 26(1)
The emergence of cellular resistances to oncolytic viruses is an underexplored process that could compromise the efficacy of cancer virotherapy. Here, we isolated and characterized B16 mouse melanoma cells that evolved resistance to an oncolytic vesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa02e23c7d065f2b488bf623f669ad49
https://pubmed.ncbi.nlm.nih.gov/36590165
https://pubmed.ncbi.nlm.nih.gov/36590165
Autor:
Serena Orlando, Carla Domuro, Isabel Fariñas, Oriol Bachs, Edurne Gallastegui, Laura Sin, Maria Jesús Pujol, Rosa Aligué, Joan Serratosa, Arnaud Besson, Alejandra Larrieux, Jonatan Martinez, José Manuel Morante-Redolat
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Oncotarget
Oncotarget, Impact journals, 2018, 9 (23), pp.16368-16379. ⟨10.18632/oncotarget.24687⟩
Dipòsit Digital de la UB
Universidad de Barcelona
instname
Oncotarget
Oncotarget, Impact journals, 2018, 9 (23), pp.16368-16379. ⟨10.18632/oncotarget.24687⟩
Dipòsit Digital de la UB
Universidad de Barcelona
Alpha-synuclein (α-SYN) is the main component of anomalous protein aggregates (Lewy bodies) that play a crucial role in several neurodegenerative diseases (synucleinopathies) like Parkinson’s disease and multiple system atrophy. However, the mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ee65911b9c2f60fd93ba698f8ae3f4
http://hdl.handle.net/10261/177158
http://hdl.handle.net/10261/177158
